These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2896030)

  • 1. Lymphocyte aggregation in response to adrenergic stimulation.
    Hammerschmidt DE; Jeanneret C; Husak M; Lobell M; Jacob HS
    Blood; 1988 May; 71(5):1470-4. PubMed ID: 2896030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human lymphocyte aggregation?
    Lazzari MA; Schattner MA; Finiasz M; Gimeno M
    Prostaglandins Leukot Med; 1984 Sep; 15(3):303-16. PubMed ID: 6436835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenoceptor antagonists and human platelets: relationship of effects to lipid solubility.
    Kerry R; Scrutton MC; Wallis RB
    Biochem Pharmacol; 1984 Aug; 33(16):2615-22. PubMed ID: 6147145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arachidonic acid, leukotriene B4, and neutrophil activation.
    Naccache PH; Sha'afi RI
    Ann N Y Acad Sci; 1983; 414():125-39. PubMed ID: 6322649
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of beta-adrenergic agents on the murine lymphocyte response to mitogen stimulation.
    Johnson DL; Ashmore RC; Gordon MA
    J Immunopharmacol; 1981; 3(2):205-19. PubMed ID: 6121831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose aspirin, platelet function and prostaglandin synthesis: influence of epinephrine and alpha adrenergic blockade.
    Rao GH; Reddy RK; White JG
    Prostaglandins Med; 1981 May; 6(5):485-94. PubMed ID: 6115432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
    Johnson GJ; Leis LA; Francis GS
    Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of benzydamine on leukocyte aggregation].
    Wurl M; Fritsch H; Müller-Peddinghaus R
    Arzneimittelforschung; 1987 May; 37(5A):614-7. PubMed ID: 3113441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of bivalent cations and arachidonic acid in neutrophil aggregation.
    O'Flaherty JT
    Inflammation; 1980 Jun; 4(2):181-94. PubMed ID: 6771213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of chemotactic factor-induced neutrophil responsiveness by arachidonic acid.
    Naccache PH; Molski TF; Volpi M; Mackin WM; Becker EL; Sha'afi RI
    J Cell Physiol; 1983 Jun; 115(3):243-8. PubMed ID: 6406520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adrenergic blockers on platelet aggregation.
    Orts A; Martí JL; Marco J; Baltar I; Castejón J
    Rev Esp Fisiol; 1979 Sep; 35(3):269-72. PubMed ID: 41294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of malonyldialdehyde production during sodium arachidonate-induced polymorphonuclear leukocyte aggregation.
    Panus PC; Eddy LJ; Longenecker GL
    J Pharmacol Methods; 1985 Apr; 13(2):179-86. PubMed ID: 3920449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arachidonic acid metabolites in the action of a beta adrenergic agonist on human monocyte phagocytosis.
    Borda ES; Tenenbaum A; Sales ME; Rumi L; Sterin-Borda L
    Prostaglandins Leukot Essent Fatty Acids; 1998 Feb; 58(2):85-90. PubMed ID: 9578144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired expression and functional activity of the beta 3- and beta 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice.
    Collins S; Daniel KW; Rohlfs EM; Ramkumar V; Taylor IL; Gettys TW
    Mol Endocrinol; 1994 Apr; 8(4):518-27. PubMed ID: 7914350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenoceptor antagonists (non-selective as well as beta 1-selective) with partial agonistic activity decrease beta 2-adrenoceptor density in human lymphocytes. Evidence for a beta 2-agonistic component of the partial agonistic activity.
    Brodde OE; Schemuth R; Brinkmann M; Wang XL; Daul A; Borchard U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):130-8. PubMed ID: 2875397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of beta-adrenergic agonists on metabolic activations of human neutrophils.
    Taniguchi K; Masuda Y; Takanaka K
    J Pharmacobiodyn; 1991 Aug; 14(8):435-42. PubMed ID: 1685514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
    O'Flaherty JT; Hammett MJ; Shewmake TB; Wykle RL; Love SH; McCall CE; Thomas MJ
    Biochem Biophys Res Commun; 1981 Nov; 103(2):552-8. PubMed ID: 6277309
    [No Abstract]   [Full Text] [Related]  

  • 19. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation.
    Clancy RM; Dahinden CA; Hugli TE
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7200-4. PubMed ID: 6417666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic beta-adrenergic therapy on the human lymphocyte response to concanavalin A.
    Johnson DL; Gordon MA
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):377-80. PubMed ID: 6113624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.